Press release
May 5, 2026
Atomera Provides First Quarter 2026 Results
Atomera Inc (ATOM)
Atomera Provides First Quarter 2026 Results
LOS GATOS, Calif. — May 5, 2026 — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2026.
Recent Company Highlights
· Completed $25 Million registered direct offering of common stock
· MST in Gate-All-Around structures has moved into the evaluation phase for customers
· Expanded GaN offerings to RF applications demonstrating breakthrough improvements to enhance RF performance
Management Commentary
“We made excellent progress during the first quarter toward adoption of MST by GAA manufacturers, engaging with another of the four companies that manufacture those advanced transistors. At the same time, we expanded our offerings in GaN beyond power applications to RF where we believe we will substantially grow our TAM and deliver highly differentiated device performance on larger-diameter wafers,” said Scott Bibaud, President and CEO of Atomera. “We are also very pleased to have closed on a $25 million equity raise which brought our cash, cash equivalents and short-term investments to over $41 million. With this additional capital we are in a strong position to enable our customers to bring MST-enabled products to market.”
Financial Results
The Company incurred a net loss of ($6.1) million, or ($0.17) per basic and diluted share in the first quarter of 2026, compared to a net loss of ($5.2) million, or ($0.14) per basic and diluted share, for the first quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the first quarter of 2026 was a loss of ($4.9) million compared to an adjusted EBITDA loss of ($4.4) million in the first quarter of 2025.
The Company had $41.1 million in cash, cash equivalents and short-term investments as of Mar. 31, 2026, compared to $19.2 million as of December 31, 2025.
The total number of shares outstanding was 38.7 million as of Mar. 31, 2026.
1
First Quarter 2026 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, May 5, 2026
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST ® ), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow –
2
Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)
March 31, December 31,
2026 2025
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 14,160 $ 19,210
Short-term investments 26,930 –
Accounts receivable 41 –
Interest receivable 139 54
Prepaid expenses and other current assets 788 338
Total current assets 42,058 19,602
Property and equipment, net 51 60
Security deposit 14 14
Operating lease right-of-use asset 1,176 884
Financing lease right-of-use asset 322 533
Total assets $ 43,621 $ 21,093
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 677 $ 608
Accrued expenses 213 168
Accrued payroll related expenses 782 650
Current operating lease liability 301 147
Current financing lease liability 106 420
Deferred Revenue 96 7
Total current liabilities 2,175 2,000
Long-term operating lease liability 896 712
Total liabilities 3,071 2,712
Commitments and contingencies – –
Stockholders’ equity: – –
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock: $0.001 par value, authorized 47,500 shares; 38,723 shares issued and 38,716 outstanding as of March 31, 2026; and 32,354 shares issued and outstanding as of December 31, 2025 39 32
Additional paid in capital 288,301 260,043
Other comprehensive income (loss) (23 ) –
Accumulated deficit (247,767 ) (241,694 )
Total stockholders’ equity 40,550 18,381
Total liabilities and stockholders’ equity $ 43,621 $ 21,093
3
Atomera Incorporated
Condensed Statements of Operations
(in thousands, except per share data)
Three Months Ended
March 31, December 31, March 31,
2026 2025 2025
(Unaudited) (Unaudited) (Unaudited)
Revenue $ 11 $ 50 $ 4
Cost of revenue (126 ) (131 ) –
Gross profit (loss) (115 ) (81 ) 4
Operating expenses
Research and development 3,457 2,740 3,255
General and administrative 2,333 1,505 2,088
Selling and marketing 419 286 124
Total operating expenses 6,209 4,531 5,467
Loss from operations (6,324 ) (4,612 ) (5,463 )
Other income (expense)
Interest income 197 195 270
Accretion income 57 – 6
Interest Expense (4 ) (9 ) (21 )
Other income (expense), net 1 1 (1 )
Total other income (expense), net 251 187 254
Net loss $ (6,073 ) $ (4,425 ) $ (5,209 )
Net loss per common share, basic and diluted $ (0.17 ) $ (0.14 ) $ (0.17 )
Weighted average number of common shares outstanding, basic and diluted 35,256 31,590 30,243
4
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)
Three Months Ended
March 31, December 31, March 31,
2026 2025 2025
Net loss (GAAP) $ (6,073 ) $ (4,425 ) $ (5,209 )
Depreciation and amortization 9 13 12
Stock-based compensation 1,406 1,334 1,009
Interest income (197 ) (195 ) (270 )
Accretion income (57 ) – (6 )
Interest expense 4 9 21
Other (income) expense, net (1 ) (1 ) 1
Net loss non-GAAP EBITDA $ (4,909 ) $ (3,265 ) $ (4,442 )
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com
5